BBCs Eurovision Dilemma Strategic Reassessment Needed After Four Years of Underperformance Bank Millennium SA Maintaining a Steady Position in Polands Evolving Banking Landscape Nvidia Earnings in Focus AI Rally Hangs in the Balance Sam Altman OpenAI and Microsoft Prevail in HighProfile AI Court Battle Corn Futures End Week on Positive Note Supported by Weather and Export Demand Ferraris 550000 Electric Car Launch Luce Design Sparks Criticism Shares Tumble SpaceX Leans on Starlink Revenue as It Prepares for Potential Nasdaq Listing SP 500 Extends Winning Streak Dow Jones Closes Week with Over 2 Gains Trade Court Ruling Invalidates Trumps 10 Blanket Tariffs Fed Minutes Signal Potential Rate Hikes if Iran Conflict Sustains Inflationary Pressures GTM Q1 2026 Earnings EPS Beats Estimates Amid Profitability Focus RITM Q1 2026 Earnings Modest EPS Beat Highlights Stability in Mortgage Real Estate BNR Q3 2022 Earnings EPS Surpasses Estimates Despite Revenue Discretion and Stock Decline OUTFRONT Media Inc OUT Q1 2026 Earnings EPS Surprises Positive as Revenue Visibility Remains Limited INTC Q1 2026 Earnings Major EPS Beat Amid Mixed Signals RWTQ Q1 2026 Earnings EPS Misses Estimates Amid Elevated Mortgage Credit Costs NovaBay Pharmaceuticals NBY Jumps 226 as Trading Volume Surges Smurfit WestRock SW Rises 17 as Shares Approach Key Resistance Level Organogenesis Holdings ORGO Holds Steady at 266 Consolidation Phase in Play Prestige Consumer Healthcare PBH Holds Near 48 as Modest Decline Tests Support Zone FBS Global Limited FBGL Surges 1034 Navigating Key Resistance at 068 ROP Q1 2026 Earnings EPS Surpasses Estimates with 258 Beat Stock Edges Higher ACI Worldwide Q1 2026 Earnings Strong EPS Beat Powered by Operational Efficiency SPRB Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Progress Continues EFSC Q1 2026 Earnings EPS Misses Estimates Despite Positive Market Reaction SUNC Q1 2026 Earnings Significant EPS Miss Raises Concerns Kevin Warshs Potential Fed Shift Could Reshape Wall Streets Market Plumbing PLX Q1 2026 Earnings Massive EPS Surprise Amid Revenue Disclosures SAB Biotherapeutics SABS Slides 381 as Biotech Sector Faces Headwinds Key Support Tested